Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06162494 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 1 to 3v5
  2. Enrollment target: 120 to 80
    • Study completion date: Sep 30, 2027 to Sep 30, 2028
    v4
  3. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Dec 5, 2023 to Mar 18, 2024
    • Eligibility criteria revised
    • Site contact updated
    v3
  4. Eligibility criteria shortened, about 1 word
    • Study description expanded, about 3 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This goal of this study is to assess the safety and immunogenicity of recombinant zoster virus in young adult solid organ transplant recipients. In this study, participants will receive the recombinant zoster vaccine. They will be monitored for adverse events and tested for antibody and cellular immunity.
Trial Details
NCT Number NCT06162494
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: Children's Hospital Colorado, Children's Hospital Medical Center, Cincinnati
Conditions
(from sponsor)		 Varicella Zoster
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov